(20s) - protopanaxadiol
Application Of Protopanaxadiol
20s) - Protopanaxadiolum (20 epiprotopanaxadiolum) est glycosidica ligandi metabolicae derivationis protopanaxadioli ginsenoside et apoptosis inducentis.
Nomen Protopanaxadiol
Nomen Anglicum :(20S)-protopanaxadiol
Chinese Alias : 20 (s) - protopanaxadiol |protopanaxadiol (PPD)
Biological Actio Protopanaxadiol
Descriptio: (20s) - protopanaxadiolum (20 epiprotopanaxadiolum) est glycosidica ligandi metabolicae derivationis protopanaxadioli ginsenoside et apoptosis inducentis.
Genera Related: iter significantem transmembranam transmembranam > > P-glycoprotein
Natural Products >> steroids
Investigatio Field > > cancer
Editio : [1] Liu GY, et al.20S-protopanaxadiol-protopanaxadiolo programma cellulae mortis inductus in cellulis glioma per vias caspase-dependens et independentes.J Nat Prod.2007 Feb;70 (2): 259-64.
[2].Zhao Y, et al.20S-protopanaxadiol vetat P-glycoprotein in cellulis cancer multidrug repugnant.Planta Med.2009 Aug;75 (10): 1124-8.
Physicochemical Proprietates De Protopanaxadiol
Densitas: 1.0 ± 0.1 g / cm3
Fervens: 559.5 ± 40.0 ° C ad 760 mmHg
Formulae hypotheticae: c30h52o3
Pondus hypotheticum: 460,732
Flash Point: 226.1 ± 21.9 ° C
Exacta Missa: 460.391632
PSA: 60.69000
LogP: 7.59
Vapor Pressura: 0.0 ± 3.5 mmHg in 25° C
Index refractivus: 1.529
English Alias Of Protopanaxadiol
Protopanaxadiol
Protopanaxtriol
(20S) -Protopanaxadiol
20(S) -Protopanaxdiol
(3β,12β)-Dammar-24-ene-3,12,20-triol
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd
Jiangsu Yongjian Pharmaceutical Technologia Co, Ltd, constituta in Martio MMXII, est summus tech incepti integralis R & D, productio et venditio.Maxime incumbit in productione, customizatione et processu productionis rerum actuum naturalium productorum, tradito medicinali Sinensi materiae referentis et inquinamentis medicamentorum.Societas Pharmaceutical in Sinis sita, urbs Taizhou, Provincia Jiangsu, cum 5000 quadratum metrorum productio basis et 2000 metrorum quadratorum R & D basis.Maioribus investigationibus scientificis inservit Institutis, universitatibus et inceptis productionis decoctionis partium per regionem.
Hactenus, plus quam 1500 genera mixtorum naturalium re- gentium elaboravimus et comparavimus et calibravimus plusquam 300 species materiae referentiae, quae in inspectione cotidianae investigationis maioris investigationis scientificae Institutorum, universitatum, laboratoriae et decoctionis fragmenta inceptis productionibus plene occurrere possunt.
Ex principio bonae fidei, societas sperat se sincere cooperari cum clientibus nostris.Propositum est nostrae modernizationi traditae Sinicae medicinali inservire.
Prodest negotium ambitus societatis;
1. R & D, productio et venditio materiae chemicae referentis medicinam traditam Sinensis;
2. customized traditum Seres medicina monomer componit secundum proprietates mos
3. Investigatio de qualitate regulae et processu evolutionis medicinae traditae Sinensi (plantae) extracti
4. Technologia cooperatio, translatio et nova investigatio medicamentorum et progressus.
